The absence of CD4+ T cells can impede the eradication of tumor cells, and research has demonstrated that inactivation of the oncogene MYC can recruit CD4+ T cells to the tumor site and induce sustained regression of tumors (38). This evidence concerns the gene CD4 and neoplasm.